2014
DOI: 10.1007/s13277-013-1582-5
|View full text |Cite
|
Sign up to set email alerts
|

The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers

Abstract: We analyzed the associations of the NOS2 (CCTTT)n promoter polymorphism to lung cancer risk and tumor histology in smokers and non-smokers. We also investigated lung cancer long-term survival in relation to the polymorphism, smoking data, histology, age at diagnosis, and gender. One hundred eighty-five lung-cancer patients and 164 matched controls, where non-smokers were enriched among the lung cancer cases, were genotyped by fragment analysis and sequencing. Genotypes were combined with information on histolo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…2014 ; Chang etal. 2015 ; Ryk etal. 2014 ), and a series of repeats in the AVPR1A gene’s promoter region, which have been associated with social behavior in voles, mice and humans ( Donaldson and Young 2013 ; Hammock and Young 2005 ; Wang etal.…”
Section: Introductionmentioning
confidence: 99%
“…2014 ; Chang etal. 2015 ; Ryk etal. 2014 ), and a series of repeats in the AVPR1A gene’s promoter region, which have been associated with social behavior in voles, mice and humans ( Donaldson and Young 2013 ; Hammock and Young 2005 ; Wang etal.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies showed that the long allele of NOS2 gene polymorphism is associated with a reduced risk of lung cancer, especially among non-smokers. 39 Previous studies have shown that they have determined the tumorigenic effect of CD2 on the growth of Lewis lung cancer cells transplanted in C57/BL6 mouse. The results showed that CD2 + cells could effectively accelerate tumor growth in vivo.…”
Section: Discussionmentioning
confidence: 99%